COVID-19: A promising cure for the global panic

B Vellingiri, K Jayaramayya, M Iyer… - Science of the total …, 2020 - Elsevier
The novel Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is the
causative agent of a potentially fatal disease that is of great global public health concern …

QSAR without borders

EN Muratov, J Bajorath, RP Sheridan… - Chemical Society …, 2020 - pubs.rsc.org
Prediction of chemical bioactivity and physical properties has been one of the most
important applications of statistical and more recently, machine learning and artificial …

Concepts of artificial intelligence for computer-assisted drug discovery

X Yang, Y Wang, R Byrne, G Schneider… - Chemical …, 2019 - ACS Publications
Artificial intelligence (AI), and, in particular, deep learning as a subcategory of AI, provides
opportunities for the discovery and development of innovative drugs. Various machine …

Generative machine learning for de novo drug discovery: A systematic review

DD Martinelli - Computers in Biology and Medicine, 2022 - Elsevier
Recent research on artificial intelligence indicates that machine learning algorithms can
auto-generate novel drug-like molecules. Generative models have revolutionized de novo …

One molecular fingerprint to rule them all: drugs, biomolecules, and the metabolome

A Capecchi, D Probst, JL Reymond - Journal of cheminformatics, 2020 - Springer
Background Molecular fingerprints are essential cheminformatics tools for virtual screening
and map** chemical space. Among the different types of fingerprints, substructure …

Automatic chemical design using a data-driven continuous representation of molecules

R Gómez-Bombarelli, JN Wei, D Duvenaud… - ACS central …, 2018 - ACS Publications
We report a method to convert discrete representations of molecules to and from a
multidimensional continuous representation. This model allows us to generate new …

From machine learning to deep learning: progress in machine intelligence for rational drug discovery

L Zhang, J Tan, D Han, H Zhu - Drug discovery today, 2017 - Elsevier
Highlights•Six commonly used machine learning methods in QSAR models are
summarized.•Newly developed combinatorial QSAR and hybrid QSAR methods are …

Deep learning in virtual screening: recent applications and developments

TB Kimber, Y Chen, A Volkamer - International journal of molecular …, 2021 - mdpi.com
Drug discovery is a cost and time-intensive process that is often assisted by computational
methods, such as virtual screening, to speed up and guide the design of new compounds …

Molecular docking and structure-based drug design strategies

LG Ferreira, RN Dos Santos, G Oliva, AD Andricopulo - Molecules, 2015 - mdpi.com
Pharmaceutical research has successfully incorporated a wealth of molecular modeling
methods, within a variety of drug discovery programs, to study complex biological and …

Molecular generative model based on conditional variational autoencoder for de novo molecular design

J Lim, S Ryu, JW Kim, WY Kim - Journal of cheminformatics, 2018 - Springer
We propose a molecular generative model based on the conditional variational autoencoder
for de novo molecular design. It is specialized to control multiple molecular properties …